Within the coding region of the dopamine D receptor (D R), two synonymous polymorphisms, D R /'&) and D R / $!) , have been identified and postulated to correlate with the schizophrenia phenotype. Binding studies revealed that the density of these genetic variants was much lower than the density of wild type D R in the human embryonic kidney (HEK) 293 cell line, used as a model system. From the data obtained using MFOLD software it is apparent that the G198A mutation has a greater impact on the secondary structure of the mRNA, which may affect its translation. However, the G1263A mutation is localized within the serine 421 codon of D R, which is predicted to be a potential site of phosphorylation according to the PHOSIDA database. In order to determine whether the studied synonymous polymorphisms influence the process of dopamine D -D receptors heterodimerization, we employed fluorescence resonance energy transfer (FRET) technology. The dopamine D receptor (D R) was tagged with cyan fluorescence protein and the D R and its genetic variants were tagged with yellow fluorescence protein. The degree of D -D receptor hetero-dimerization was significantly decreased when genetic variants of D R were co-expressed with D R. Since the D R mutations affected the expression levels of the proteins in the cell membrane without affecting the cellular localization of the receptor proteins, we postulated that the D R polymorphisms altered the translation rate and protein structure of the receptor. The altered hetero-dimerization that likely results from the lower expression of these genetic variants of D R with D R may be partially responsible for the association of both G198A and G1263A polymorphisms with the schizophrenia phenotype. 
Introduction
As dysfunctions in the brain dopaminergic system are involved in a variety of important disorders including Parkinson's disease, schizophrenia, Tourette syndrome and drug abuse, dopaminergic receptors are often targeted in the treatment of these disorders. In addition to the development of drugs, potential links between dopamine receptor polymorphisms (single-nucleotide sequence variations) and neuropsychiatric diseases have been the subject of extensive research with the advancement of molecular biology techniques. Besides the restriction fragments length polymorphism recognized by EcoR1 [17] and TaqI [27] , three other polymorphisms were reported by Liu et al. [28] , a -48A/G substitution in the 5' untranslated region of exon 2, and 198G/A and 1263G/A substitutions.
Although none of these polymorphisms confer a functional amino acid change, some genetic studies have linked them to schizophrenia [31] . Not many studies have investigated these polymorphisms, as it had been widely assumed that silent (synonymous) mutations do not alter the biological activity or pharmacological profile of the receptor. However, data indicating the role of synonymous mutations in the biosynthesis of proteins are emerging [5, 9, 14, 23, 34, 37, 39] . Thus, we decided to address the question of whether two silent mutations within the coding region of the dopamine D 1 receptor (D 1 R) -D 1 G198A and D 1 G1263A -would influence its binding parameters as well as its hetero-dimerization with the dopamine D 2 receptor (D 2 R). The hetero-dimerization issue is important especially in light of the emerging concept of G protein-coupled receptor (GPCR) hetero-dimerization, but also to better understand mechanism of action of therapeutic agents. We have recently shown that at least a subset of dopamine D 1 and D 2 receptors form hetero-dimers, and that specific ligands can affect hetero-dimerization [10, 30] . Also, co-expression of both receptors in the same cell has a pronounced effect on the affinity of antipsychotic drugs [11] , indicating that physical interaction of these receptors may be an important issue in the field of drug design.
To better understand D 1 -D 2 receptor dimerization processes we have adapted a strategy previously described in our studies [10, 11, 30] that allows the monitoring of the physical interactions between receptor proteins in a single living cell. The investigated receptors were labeled with cyan (CFP, fluorescence donor) and yellow (YFP, fluorescence acceptor) fluorescent proteins and expressed in HEK293 (human embryonic kidney) cells. Based on measurements of fluorescence resonance energy transfer (FRET) occurring between fluorescently tagged proteins, the receptor dimer formation was estimated.
Materials and Methods

Materials
HEK293 cells were obtained from the American Type Culture Collection (Manassas, VA, USA). All cell culture reagents were purchased from Gibco (Carlsbad, CA, USA) and Sigma (Poznañ, Poland). The bacterial cell line Escherichia coli DH5a (Dam+) was obtained from Novagen (Darmstadt, Germany).
All molecular biology reagents were obtained from Fermentas (Vilnius, Lithuania). Oligonucleotides were synthesized by IBB PAN (Warszawa, Poland). The pcDNA3.1(+) plasmids encoding human D 1 and D 2 receptors were obtained from UMRcDNA Resource Center (University of Missouri, Rolla, MO, USA). The pECFP-N1 and pEYFP-N1 vectors were purchased from BD Biosciences, Clontech (Palo Alto, CA, USA).
Construction of genetic variants of the dopamine receptors
Two genetic variants of the D 1 R: D 1 R G198A and D 1 R G1263A were constructed. The appropriate point mutations exchanging the guanine nucleotide to adenine were produced according to the Quik Change Site-Directed Mutagenesis Kit (Stratagene, LA Jolla, CA, USA). PCR-Quik reactions were performed with pcDNA3.1(+)/D 1 as the template and the following sets of oligonucleotide primers each containing the desired mutations: D1G198A: forward (5'-TTA-3'), reverse (5'-TAA-3'); D1G1263A: forward (5'-TCA -3'), reverse (5'-TGA-3'). Next, the reaction product was treated with the methylation-specific endonuclease DpnI in order to select synthesized DNA containing the introduced mutations. E. coli cells were transformed with the mutated plasmids.
Construction of fusion proteins
The cDNAs encoding genetic variants of human D 1 Rs were amplified with a universal forward primer for pcDNA3.1(+) and a reverse primer that obliterated the stop codon and introduced a unique restriction site for XhoI. The resulting fragments were inserted inframe into NheI/XhoI sites of the pEYFP-N1 vector. The construction of fusion proteins D 1 tagged with YFP and D 2 tagged with CFP was described previously [29] .
Cell culture and transfection
HEK293 cells were cultured at 37°C in a humidified atmosphere of 5% CO 2 . Cells were maintained in Dulbecco's modified essential medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum and 1% L-glutamine. A day before transient transfection, the cells were seeded into 100 mm dishes (3 × 10 6 cells per dish) for radioligand binding assays, or on cover glass slips in 30 mm dishes (1 × 10 6 cells per dish) for confocal microscopy and fluorescence lifetime measurements. HEK293 cells were transiently transfected with 15 µg of DNA per 100 mm dish or with 2 µg of DNA per glass cover slip using a calcium phosphate precipitation method as described by Sambrook et al. [36] . The ratio of DNA encoding donor to acceptor was 1:1 or 1:2. Forty-eight hours after transfections cells were harvested or microscopic measurements were taken.
Membrane preparation and radioligand binding assay
For binding experiments the transfected HEK293 cells were washed with phosphate-buffered saline (PBS), scraped from the dish in PBS and centrifuged for 5 min at 160 g. The resulting cell pellet was frozen at -30°C. Frozen pellets were resuspended in binding buffer [50 mM Tris-HCl pH 7.4 containing 120 mM NaCl, 5 mM KCl, 4 mM MgCl 2 , 1,5 mM CaCl 2 and 1 mM EDTA] using an Ultra Turrax homogenizer. The homogenate was centrifuged twice for 15 min at 16,500 g (4°C). Following the modified Lowry's procedure the protein content of membrane preparations was determined, using bovine serum albumin as a standard.
Binding assays were performed in a total volume of 0.5 ml using concentrations of [ 3 H]SCH23390 (SA 85 Ci/mmol, NEN, Boston MA, USA) ranging from 0.12 nM up to 8 nM. Saturation studies were performed on a fresh membrane preparation (final protein concentration 15-20 µg per tube). Nonspecific binding was assessed with 10 µM cis-(Z)-flupentixol (Lundbeck, Copenhagen, Denmark). Binding assays were incubated for 2 h at room temperature and terminated by rapid filtration through glass fiber filters (GF/C Whatman). The filters were washed four times with 5 ml of ice-cold wash buffer [50 mM Tris-HCl pH 7.4]. The amount of bound radioactivity was determined by liquid scintillation quantification (Beckman LS 650).
The radioligand binding parameters K d and B max were estimated with the GraphPad Prism 4.0 curvefitting program (GraphPad Software, San Diego, CA, USA).
Measurements of FRET by Fluorescence Lifetime Microscopy
To monitor whether the FRET phenomenon occurs between receptor proteins tagged with fluorescent protein CFP (donor) and YFP (acceptor), quantitative methods were used. Measurements of FRET by fluorescence lifetime microscopy in a single living cell expressing the investigated receptors in different combinations (performed on the Nikon Eclipse TE-2000 inverted fluorescence microscope) were performed at 37°C, 48 h after transfection. During each experiment, the fluorescence decay from at least 10 cells was measured. For each combination of receptors at least 4 independent experiments were conducted. Fluorescence intensity decays were analyzed as both mono-and multi-exponentials. Analysis of the reduced c 2 value and residual distribution has led to the conclusion that best fit parameters were obtained with two exponentials. The analysis parameters were not significantly influenced by an additional third exponential, and the fractional contribution of the additional lifetime approximated zero. Statistical analysis was performed using one-way ANOVA followed by a Dunnett's test for post-hoc comparisons. Detailed information on the statistical analysis is described in our previous papers [10, 11, 29, 30] .
Confocal microscopy
Analysis of the localization of investigated receptor fusion proteins in HEK293 was performed with confocal microscopy. Images were acquired with two systems: a Leica TCS SP2 (Leica Microsystem, Mannheim, Germany) equipped with an acusto-optical beam splitter and a 100 mW argon laser for excitation at 458 nm (CFP) and 514 nm (YFP) described previously [15] , and a BioRad MRC 1024 confocal system (BioRad) interfaced with a Nikon Diapoth 300 (Nikon) inverted microscope. The microscope was equipped with a 60× PlanApo oil-immersion 1.4 NA objective lens and a 100 mW argon ion air-cold laser (ITL). Detailed information is provided in a previous publication [30] .
Colocalisation analysis was performed with Image ProPlus 4.5 software. Pearson's correlation coefficient as a measure of the overlap of pixels was also determined. Pearson's correlation coefficient was calculated from randomly selected parts of the image from individual cells cotransfected with different combinations of D 2 R tagged with CFP and wild-type or polymorphic variants of D 1 R fluorescently tagged with YFP. A subtracted background of each image was the average intensity of the fluorescence signal in a determined individual area of interest (AOI), free of cells. Regions with correlated fluorescence intensities were used for further analysis. For each combination of the proteins, at least 10 individual regions from different, independently transfected cells were analyzed and Pearson's correlation coefficients were calculated. The statistical significance was assessed with one-way ANOVA followed by a Dunnett's test for post-hoc comparisons.
Results
Radioligand binding assay
As evident in Figure 1 , both mutants of the dopamine D 1 receptor (D 1 R G198A and D 1 R G1263A ) displayed significantly lower expression compared to wild type D 1 R in HEK293 cells.
For both mutants, the receptor density values (B max ) were lower than the control value; however, much less of the D 1 R G198A than D 1 R G1263A was produced in the cells. Despite this, all of these receptors were functionally similar, as evidenced by the similar K d values estimated for all three genetic variants of D 1 R (Tab. 1).
Fluorescence lifetime microscopy studies of dopamine receptor dimerization
To study the physical interaction of D 1 R and its mutants with D 2 R, we monitored the FRET. 
Co-localization analysis
Cells co-expressing D 2 R with genetic variants of D 1 R were visualized by confocal microscopy. These experiments were performed to determine whether the introduced synonymous mutations within the D 1 R in any way influenced the cellular localization of the studied receptors. The degree of co-localization of the receptors of interest was quantitatively estimated by the Pearson's correlation coefficient. As evident in Figure 2B , these parameters do not differ, which indicates that there is no change in the localization between the wild type D 1 
Proposed mRNA secondary structure models
The relationship between the mRNA secondary structure and gene expression is widely postulated. Taking this into account, we modeled the effect of synonymous polymorphisms on the D 1 R mRNA secondary 
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Katarzyna Grymek et al. Fig. 1 A B calized mainly within the loop structure. In Figure 3 , examples of mRNA secondary structures are shown.
Discussion
The present study addressed whether synonymous mutations within the coding region of the D 1 R, which has been reported in some studies to be linked to the schizophrenia phenotype and/or the altered drug response [28] , impact parameters characteristic of D 1 R function. Binding studies revealed that the density of D 1 R G198A is much lower than the density of wild type D 1 R in the heterologous expression model system. The second genetic variant of D 1 R, the D 1 R G1263A , is also expressed to a lesser degree than wild type D 1 R, although our results indicate that it is expressed more efficiently than D 1 R G198A . Such results indicate that two polymorphisms within the coding region of D 1 R, although designated as "silent" because they do not change the amino acid sequence, are not silent at all since they significantly change the amount of receptor present on the cell membrane. From the data obtained using MFOLD software we could observe the potential impact of the studied SNPs on the secondary structure of the mRNA. The mRNA structure was affected more in the G198A mutant, which is consistent with the experimental data showing a lower level of expression of D 1 R on the cell membrane.
The molecular mechanism underlying these observations likely involves the translational stage of receptor biosynthesis. Recently, convincing data have been provided indicating that synonymous mutations can have a profound impact on the kinetics of translation, as the least common codon requires a less abundant tRNA species [23] .
Furthermore, Tsai et al. [39] suggested that synonymous mutations cause so-called ribosome stalling. In their elegant discussion, they hypothesize that sufficient translational stalling signals introduced by mutations may lead to formation of an altered protein. The present studies of the physical interaction of D 2 R with genetic variants of D 1 R partially confirm this suggestion. We did not observe any change in the K d value, which is commonly regarded as an indicator of the lack of conformational changes within the protein structure, in the domains responsible for ligand binding. However, the interaction with D 2 R was altered, as indicated by the FRET experiments. The observed change in the hetero-dimerization of genetic variants of D 1 R with D 2 R did not result from the altered localization of these receptors, as the mutants co-localized with D 2 R in the cell membrane to the same extent as observed for the wild type D 1 R. However, one possible explanation is that the less pronounced heterodimerization of the studied receptors may result from the lower expression level of the genetic variants of D 1 R. In addition to the main question of the present study, our data speak in favor of the biophysical methodology used to monitor the physical interaction of receptor proteins, which is sensitive to changes in their expression level.
However, different molecular mechanisms have been described for the protein-protein interactions that occur during receptor dimerization processes [1, 4, 13, 16, 18, 19, 22, 24, 32, 33, 44] . Electrostatic interactions are also considered effectively engaged in the formation of stable noncovalent complexes between proteins. This kind of interaction may occur between characteristic epitopes, one containing the cationic guanidinium groups (located at the terminus of the arginine side chain) and the other one containing the anionic carboxyl groups of aspartate or glutamate and/or the anionic phosphate group on the phosphorylated residue [2, [40] [41] [42] . Motifs composed of a minimum of two adjacent arginine residues, "RR" or "RKR", on one peptide and two adjacent aspartate "DD" or glutamate "EE" residues or/and one phosphorylated serine residue in close proximity of the other, were found to be sufficient to generate stable complexes between two peptides [20, 21, 43] . Moreover, Jackson et al. [21] demonstrated that the interaction involving just one phosphate is almost as stable as the one involving multiple glutamate residues. Additionally, the presence of a phosphorylated residue was shown to cause a significant increase in the stability of noncovalent interactions between epitopes [21] . Simultaneously, the importance of phosphorylationdephosphorylation events in the modulation of the electrostatic interactions was highlighted [42] .
Various reports suggest that the mechanisms involved in hetero-dimerization of some GPCRs are connected with the presence of the motifs described above, via neutralization of each other's charge and the formation of salt bridges [3, 12, 26] . Recently, £ukasiewicz et al. [30] demonstrated that electrostatic interactions between an arginine-rich epitope (Arg-rich) from the third intracellular loop (ic3) of the dopamine D 2 (217RRRRKR222) receptor and two adjacent glutamate residues from the carboxyl terminus of the D 1 R (404EE405) participate in a heterodimerization process between two dopamine receptors (D 1 and D 2 ) . Similar interactions were also described by Jackson et al. [20] for the D 2 R and the cannabinoid CB1 receptors and by Lee et al. [26] for the ionotropic glutamate NMDA (NR1 subunit) and the dopamine D 1 receptors. Moreover, Ciruela et al. [7] used pull-down and mass spectrometry experiments to postulate that the hetero-dimerization of the adenosine A 2A and the dopamine D 2 receptors strongly depends on electrostatic interactions between an Argrich epitope within the ic3 of D 2 R and acidic aspartate epitope from C-tail of the adenosine A 2A receptor. They also pointed to an essential role for the phosphorylation of serine 374 (localized in the C-tail sequence of the A 2A receptor within the casein kinase 1 (CK1) consensus site) in this process. Moreover, it was shown that in contrast to the CK1 consensus site, two adjacent aspartate residues were not conserved among species, which suggests that the hetero-dimerization process is likely primarily mediated by the phosphorylated epitope [7] .
It is well known that phosphorylation of serine residue plays an important role in the regulation of various cellular processes and that mutations of the phosphorylation site of a substrate can lead to the development of some disorders [8] . As the silent polymorphism G1263A investigated in the present study is localized within the serine 421 codon (C-tail) of the D 1 R , we addressed whether this serine residue could be phosphorylated.
The PHOSIDA (phosphorylation site database) server designed to identify phosphorylation sites enabled us to predict that the serine 421 residue from the C-tail of the dopamine D 1 receptor is a potential CK1 recognition site since it is localized in an epitope possessing a CK1 consensus site (S-X 3 -pS) [15, 35] . CK1 belongs to the superfamily of serine/threonine-specific protein kinases. The widespread distribution of CK1 suggests that it plays an important regulatory role for the protein [6] . Beside numerous biological functions, CK1 was also shown to enhance agonistdependent phosphorylation of the M3 muscarinic receptor and to mediate the phosphorylation of rhodopsin in response to light stimulation [6, 38] .
Since the investigated silent polymorphism (G1263A) can lead to alterations in the translation levels, what may affect structure of proteins, it seemed probable that the phosphorylation may be weakened or impaired. Therefore, the observed decrease of FRET efficiency may be a result of the abrogated heterodimerization of both dopamine receptors. This observation may be due to the alteration in the degree of phosphorylation of serine residue 421, which might be not be fully accessible to the appropriate kinase due to possible changes in receptor protein folding. Similarly to Ciruela et al. [7] , we point to a potential role for the phosphorylation phenomenon in the direct receptor association, especially in the present investigated case of dopamine D 1 -D 2 heterodimerization. It is likely that this process is also mediated by phosphorylation at this epitope.
The role of D 1 -D 2 receptor hetero-dimerization has also been indicated as important in the mechanism of action of antipsychotic drugs [11] . Therefore, the data obtained in the present paper as well as the discussion above suggest a molecular mechanism responsible for the association of both G198A and G1263A polymorphic variants of D 1 R, with altered response to antipsychotic treatment.
